Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Pilot Study of Intravitreal Bevacizumab vs. Combination Therapy for Choroidal Neovascularization Secondary to Causes Other Than Age-related Macular Degeneration

NCT01256580 is registered in ClinicalTrials.gov with Massachusetts Eye and Ear Infirmary as lead sponsor.

NCT NCT01256580
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01256580 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Pilot Study of Intravitreal Bevacizumab vs. Combination Therapy for Choroidal Neovascularization Secondary to Causes Other Than Age-related Macular Degeneration
Lead sponsor
Massachusetts Eye and Ear Infirmary
Phase
Not applicable
Overall status
Withdrawn
Start date
August 31, 2010
Completion date
September 30, 2013
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

angioid streaks, central serous chorioretinopathy (csc), choroidal neovascularization, multifocal choroiditis, myopia, ocular histoplasmosis syndrome, punctate inner choroidopathy (pic), trauma, or hereditary eye diseases